Overblog Alle Blogs
Edit post Folge diesem Blog Administration + Create my blog
MENU

Mein Blog umfasst die aktuellesten News, Forschungsleistung, neuesten Produkte und Service von Sino Biological Inc. und die aktuelle News von Life Sciences. Sie können sich hier wissenschaftlich informieren.Willkommen zu meinem Blog.Viel Spaß!

Werbung

BLVRB / biliverdin reductase B Antikörper

Sino Biological Inc. liefert BLVRB / biliverdin reductase B Antikörper mit höherer Qualität und günstiger Kosten im Vergleich mit anderen globalen Lieferanten.

Weitere Informationen über BLVRB / biliverdin reductase B Antikörper lesen Sie bitte: http://www.sinobiological.com/BLVRB-biliverdin-reductase-B-Antibody-g-10142.html

Produkt-Information von BLVRB / biliverdin reductase B Antikörper

Immunogen

Recombinant Human BLVRB / biliverdin reductase B protein (Catalog#13151-H07E)

Antibody Type Mouse Monoclonal Antibody ( Mouse mAb Service Platform )

Clone ID

02

Ig Type

Mouse IgG2b

Formulation 0.2 μm filtered solution in PBS with 5% trehalose
Preparation

This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human BLVRB / biliverdin reductase B (rh BLVRB / biliverdin reductase B; Catalog#13151-H07E; P30043; Ala 2-Gln 206). The IgG fraction of the cell culture supernatant was purified by Protein A affinity chromatography.

Usage Guide von BLVRB / biliverdin reductase B Antikörper

Specificity

Human BLVRB / biliverdin reductase B

 

No cross-reactivity in ELISA with

E.coli cell lysate

Direct ELISA This antibody can be used at 0.5-1 μg/mL with the appropriate secondary reagents to detect Human BLVRB. The detection limit for Human BLVRB is approximately 0.078 ng/well.
Storage This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -70℃. Preservative-Free.
Sodium azide is recommended to avoid contamination (final concentration 0.05%-0.1%). It is toxic to cells and should be disposed of properly. Avoid repeated freeze-thaw cycles.

Verwandte Produkte & Themen von BLVRB / biliverdin reductase B Antikörper

Related Areas:

Enzyme >>Protease & Regulator >>Serine Protease & Regulator >>Serpin Superfamily >>BLVRB

Enzyme>>Oxidoreductase>>BLVRB

Proteins:
Molecule Species Description //For Detailed Info. and Price------CLICK! Cat. No
BLVRB Human BLVRB / biliverdin reductase B Protein, Recombinant 13151-H07E
Antibodies:
Molecule Application Description //For Detailed Info. and Price------CLICK! Cat. No
Human BLVRB ELISA BLVRB / biliverdin reductase B Antibody 13151-MM02

Hintergrund von BLVRB / biliverdin reductase B Antikörper

Biliverdin reductase (hBVR) is a serine/threonine kinase that catalyzes reduction of the heme oxygenase (HO) activity product, biliverdin, to bilirubin. BVR consists of an N-terminal dinucleotide-binding domain (Rossmann-fold) and a C-terminal domain that contains a six-stranded β-sheet that is flanked on one face by several α-helices. The C-terminal and N-terminal domains interact extensively, forming the active site cleft at their interface. Biliverdin reductase (BVR) catalyzes the last step in heme degradation by reducing the γ-methene bridge of the open tetrapyrrole, biliverdin IXα, to bilirubin with the concomitant oxidation of a β-nicotinamide adenine dinucleotide (NADH) or β-nicotinamide adenine dinucleotide phosphate (NADPH) cofactor. It is now recognized that human BVR (hBVR) is a dual-specificity kinase (Ser/Thr and Tyr) upstream activator of the insulin/insulin growth factor-1 (IGF-1) and mitogen-activated protein kinase (MAPK) signaling pathways. Human BVR (hBVR) is essential for MAPK-extracellular signal-regulated kinase (ERK)1/2 (MEK)-eukaryotic-like protein kinase (Elk) signaling and has been identified as the cytoplasm-nuclear heme transporter of ERK1/2 and hematin, the key components of stress-responsive gene expression.

References

  1. Kapitulnik J. et al., 2009, Trends in Pharmacological Sciences. 30 (3): 129-37.
  2. Ahmad Z. et al., 2002, Journal of Biological Chemistry. 277: 9226-32.
  3. Whitby FG. et al., 2002, Journal of Molecular Biology. 319 (5): 1199-210.

Primary Antibody Products

Werbung
Zurück zu Home
Diesen Post teilen
Repost0
Um über die neuesten Artikel informiert zu werden, abonnieren:
Kommentiere diesen Post